The phrase "assay sensitive" is correct and usable in written English.
It is typically used in scientific or medical contexts to describe a test or method that can detect small amounts of a substance or changes in concentration.
Example: "The new assay is highly assay sensitive, allowing for the detection of trace levels of the biomarker in patient samples."
Alternatives: "highly sensitive assay" or "sensitive to assay changes".
The PCR multiplexes amplify short amplicon lengths which makes the assay sensitive to the analysis of degraded DNA.
A major challenge in neuronal stem cell biology lies in characterization of lineage-specific reprogrammed human neuronal cells, a process that necessitates the use of an assay sensitive to the single-cell level.
To characterize DNA strand-breaking activities in selected foods/beverages, flavorings, and some of their constituent chemicals, we used p53R cells, a cellular assay sensitive to such breaks.
Serum PCT was centrally determined by an immunofluorescent assay (sensitive KRYPTOR, B.R.A.H.M.S AG, Henningsdorf, Germany).
We evaluated this question using an assay sensitive for identification of ATI in the presence of infliximab.
In line with these views, we were unsuccessful in our attempts to create a competition ELISA assay sensitive enough to detect translated peptides and proteins (data not shown).
Using novel assays sensitive to single, nanometer-sized fusion pores with sub-millisecond time resolution, we study how exocytotic pores nucleate and how their dynamics are regulated.
In the FRAP assays for BRD3 and BRD4, both of which contain two bromodomains, assays sensitive to small-molecule inhibitors were possible without the addition of SAHA.
PCT sensitive Kryptor assay provides a sensitive, functional assay sensitivity of 0.06 ng/mL with results available in 19 minutes using 20 50 mL of plasma or serum [ 109].
Improved outcome was associated with the administration of an assay-sensitive therapy, regardless of homogeneous or heterogeneous assay responses across all of the assayed therapies.
Further, multivariate analysis demonstrated that an increased or decreased percentage of assay-sensitive results across all therapies tested was not associated with patient outcome when the matched assay result was included.
